Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Generally healthy postmenopausal women~* Body mass index (BMI) in the range of 18.0 to 35.0 kg/m2 and body weight \>= 50 kg~Exclusion Criteria:~* Pregnant or nursing females; females of childbearing potential

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Test Treatment 1: bazedoxifene (Type: EXPERIMENTAL): Test Treatment 1
- Test Treatment 2: bazedoxifene (Type: EXPERIMENTAL): Test Treatment 2
- Test Treatment 3: bazedoxifene (Type: EXPERIMENTAL): Test Treatment 3
- Reference Treatment: bazedoxifene/conjugated estrogens (Type: EXPERIMENTAL): Reference Treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).